About Optomed
Optomed is a company based in Alpharetta (United States) founded in 2004 by Seppo Kopsala. Optomed has raised $4.92 million across 5 funding rounds from investors including European Union, Mawell and EIC Fund. The company has 115 employees as of December 31, 2024. Optomed has completed 1 acquisition, including Commit. Optomed offers products and services including Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris. Optomed operates in a competitive market with competitors including EarlySight, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
- Headquarter Alpharetta, United States
- Employees 115 as on 31 Dec, 2024
- Founders Seppo Kopsala
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Optomed Oyj Class A
-
Annual Revenue
$15.63 M (USD)-0.4as on Dec 31, 2024
-
Net Profit
-$5.66 M (USD)-22.72as on Dec 31, 2024
-
EBITDA
-$4.89 M (USD)-71.3as on Dec 31, 2024
-
Total Equity Funding
$4.92 M (USD)
in 5 rounds
-
Latest Funding Round
$2.2 M (USD), Grant
Jul 31, 2019
-
Investors
European Union
& 6 more
-
Employee Count
115
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Optomed
Optomed is a publicly listed company on the OMXHEX with ticker symbol OPTOMED in Finland, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Optomed
Optomed offers a comprehensive portfolio of products and services, including Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris.
AI-enabled camera for instant diabetic retinopathy detection.
Fundus camera for eye screening in various settings.
Device for professional ophthalmic examinations.
Stationary fundus camera for detailed eye diagnostics.
People of Optomed
Unlock access to complete
Funding Insights of Optomed
Optomed has successfully raised a total of $4.92M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $2.2 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Optomed
Optomed has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Mawell and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Venture capital firm investing in tech startups
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Optomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optomed
Optomed has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Commit.
Investment portfolio details for Optomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Healthcare solutions are provided by Commit in Finland.
|
Locked | Locked | 1989 | Locked |
Complete acquisition details for Optomed
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Optomed
Detailed financials for Optomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optomed Comparisons
Peer comparison for Optomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optomed
Optomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EarlySight, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Retinal imaging solutions for detecting disorders are provided.
|
|
| Locked | Locked | Locked |
AI-driven retinal image analysis for diabetic retinopathy detection is developed.
|
|
| Locked | Locked | Locked |
Non-mydriatic hand-held devices for visual electrophysiology testing are developed.
|
|
| Locked | Locked | Locked |
Diagnostic imaging devices are developed for early eye disease detection.
|
|
| Locked | Locked | Locked |
Application that allows 3D capture using single standard camera
|
Detailed competitors of Optomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optomed
Complete news archive for Optomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optomed
Optomed was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Optomed is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Seppo Kopsala is the current CEO of Optomed. They have also founded this company.
Optomed is a funded company, having raised a total of $4.92M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Optomed is 115.
Annual revenue of Optomed is $15.63M as on Dec 31, 2024.
Optomed was founded in 2004 and is headquartered in Alpharetta, United States. Handheld fundus cameras integrated with software and artificial intelligence are developed for screening and diagnosing blinding eye diseases, including diabetic retinopathy and macular edema. Operations focus on medical imaging devices within the healthcare sector, targeting improvements in eye care diagnostics through portable technology.
Optomed's top competitors include Heidelberg Engineering, Eyenuk and Wooptix.
Optomed offers Aurora AEYE, Optomed Aurora IQ, Smartscope PRO, and Optomed Polaris.
Yes, Optomed is publicly traded on OMXHEX under the ticker symbol OPTOMED.
Optomed has made 1 acquisition, including Commit.
Optomed has 7 investors. Key investors include European Union, Mawell, EIC Fund, Robert Bosch Venture Capital, and Cenova.
The ticker symbol of Optomed is OPTOMED on OMXHEX.